 | PRD_002363 | Formula: | C73 H120 N20 O13 | Definition date: | 2020-08-12 | Last modified: | 2025-02-04 |
|
 | PRD_002397 | Formula: | C41 H72 N14 O10 S | Definition date: | 2021-03-31 | Last modified: | 2025-02-04 |
|
 | PRD_002398 | Formula: | C42 H74 N14 O10 S | Definition date: | 2021-03-31 | Last modified: | 2025-02-04 |
|
 | PRD_002399 | Formula: | C45 H68 N10 O11 S | Definition date: | 2021-03-31 | Last modified: | 2025-02-04 |
|
 | PRD_002519 | Name: | MCR-PHE-VAL-PRO-THR-THR-BIF-MAA-BIF-MAA-GLU-ALA-PRO-ALA-NEH inhibitor | Formula: | C85 H110 N14 O18 S | Definition date: | 2024-10-16 | Last modified: | 2024-10-16 |
|
 | PRD_002520 | Name: | ACE-PHE-VAL-DAB-THR-THR-PHE-MAA-BIF-YBR inhibitor | Formula: | C62 H80 N10 O14 | Definition date: | 2024-10-16 | Last modified: | 2024-10-16 |
|
 | PRD_002521 | Name: | YBX-YC3-VAL-PRO-THR-THR-PHE-MAA-CYS-MN1 inhibitor | Formula: | C60 H81 N9 O13 S3 | Definition date: | 2024-10-16 | Last modified: | 2024-10-16 |
|
 | PRD_002523 | Name: | MCR-ALO-MAA-ALA-MAA-NLE-7T2-SER-7T2-ALA-NH2 inhibitor | Formula: | C49 H70 Cl2 N10 O12 S | Definition date: | 2024-10-16 | Last modified: | 2024-10-16 |
|
 | PRD_002525 | Name: | PPI-YD5-NLE-7T2-SER-7T2-DPP-GLY-NH2 inhibitor | Formula: | C43 H59 Cl2 N9 O10 | Definition date: | 2024-10-16 | Last modified: | 2024-10-16 |
|
 | PRD_002558 | Name: | DGN-DVA-YC3-GLU-PRO-THR-THR-PHE-MAA-A1BC0 inhibitor | Formula: | C62 H84 N12 O14 S2 | Definition date: | 2024-10-16 | Last modified: | 2024-10-16 |
|
 | PRD_002234 | Formula: | C57 H91 N12 O19 | Definition date: | 2024-08-07 | Last modified: | 2024-08-07 |
|
 | PRD_002337 | Name: | INHIBITOR ARC-1411 | Formula: | C61 H119 N34 O9 | Definition date: | 2024-04-10 | Last modified: | 2024-04-10 |
|
 | PRD_002339 | Name: | Inhibitor ARC-1415 | Formula: | C55 H106 N30 O8 | Definition date: | 2024-04-10 | Last modified: | 2024-04-10 |
|
 | PRD_002404 | Name: | Dynobactin A | Formula: | C60 H78 N18 O16 | Description: | 10mer peptide with distinct cyclophane rings. | Definition date: | 2022-09-28 | Last modified: | 2024-03-26 |
|
 | PRD_002532 | Name: | N-Methyl-D-Gln4,Lys10-teixobactin | Formula: | C59 H100 N13 O15 | Definition date: | 2024-03-06 | Last modified: | 2024-03-06 |
|
 | PRD_000671 | Name: | PHQ-ILE-GLU-THR-azaASP-EP-CO-ALA-NH-CH2-PH | Formula: | C39 H53 N7 O14 | Definition date: | 2012-12-12 | Last modified: | 2024-01-09 |
|
 | PRD_002517 | Formula: | C66 H84 N10 O17 S | Definition date: | 2023-12-06 | Last modified: | 2023-12-06 |
|
 | PRD_002466 | Name: | Cyclohexyl-Griselimycin | Formula: | C63 H106 N10 O12 | Definition date: | 2023-11-29 | Last modified: | 2023-11-29 |
|
 | PRD_002467 | Name: | Mycoplanecin A | Formula: | C61 H102 N10 O13 | Definition date: | 2023-11-29 | Last modified: | 2023-11-29 |
|
 | PRD_000001 | Name: | Actinomycin D | Formula: | C62 H86 N12 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000894 | Name: | MM-102 | Formula: | C35 H50 F2 N7 O4 | Definition date: | 2013-07-31 | Last modified: | 2023-11-03 |
|
 | PRD_000006 | Name: | 8-Fluoro-Actinomycin D | Formula: | C62 H85 F N12 O16 | Description: | ACTINOMYCIN D CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXF)
THE CHROMOPHORE PXF IS A MODIFIED PXZ WITH
C-F REPLACING C-H IN POSITION 8 OF THE
PHENOXAZONE RING. | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_002435 | Formula: | C49 H86 N5 O8 | Definition date: | 2020-09-16 | Last modified: | 2023-11-03 |
|
 | PRD_000007 | Name: | Actinomycin X2 | Formula: | C62 H84 N12 O17 | Description: | ACTINOMYCIN X2 CONSISTS OF TWO PENTAMER
RINGS LINKED BY THE CHROMOPHORE (PXZ) | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000895 | Name: | MM-101 | Formula: | C35 H52 N7 O4 | Definition date: | 2013-07-31 | Last modified: | 2023-11-03 |
|